Base4 Biosciences closes a one million euro financing round

May 27, 2026

Base4 Biosciences, a startup incubated at TecnoCampus and spin-off of the Sant Pau Research Institute, has closed a funding round of one million euros to accelerate the development of a systems biology platform, an innovative technology that allows the analysis of organ aging and advances towards more precise and equitable medicine, with a special impact on reducing the gender gap in health.

 

Pol Cervera, CEO of Base4 Biosciences, together with Doctor José Manuel Soria, director of Genetics at the Sant Pau hospital, and mathematician Ángel MartínezBase4 Biosciences

Base4 bases its proposal on solid scientific support, with research published in the prestigious journal Science and a long history in the Barcelona healthcare ecosystem. This technical base has been key for the company to now be able to make a double strategic leap. 

On the one hand, it has closed a financing round of one million euros that has the support of relevant investors such as KeyFame, Pibnic (driven by the founders of Factorial) and several business angels linked to Masia VC. 

On the other hand, their location in the TecnoCampus incubator provides them with the necessary infrastructure to scale their operations and bring their technology to market.

In the photo, Pol Cervera, CEO of Base4 Biosciences, with Dr. José Manuel Soria, director of Genetics at the Hospital de Sant Pau, and mathematician Ángel Martínez.

Gallery d'imatges

Previous

The call to participate in the Business Immersion Program in Beijing is open

Next

The call for entries for the Creatic 2026 awards is open